Kumari, Puja http://orcid.org/0000-0001-8408-0914
Vasudevan, Swathy O. http://orcid.org/0000-0001-7437-8119
Russo, Ashley J.
Wright, Skylar S. http://orcid.org/0000-0002-1341-5710
Fraile-Ágreda, Víctor http://orcid.org/0000-0002-1561-1328
Krajewski, Dylan
Jellison, Evan R. http://orcid.org/0009-0004-2674-1605
Rubio, Ignacio http://orcid.org/0000-0002-0251-7711
Bauer, Michael http://orcid.org/0000-0002-1521-3514
Shimoyama, Atsushi http://orcid.org/0000-0003-1910-0450
Fukase, Koichi http://orcid.org/0000-0001-8844-0710
Zhang, Yuanpeng
Pachter, Joel S.
Vanaja, Sivapriya Kailasan
Rathinam, Vijay A. http://orcid.org/0000-0002-8009-3977
Funding for this research was provided by:
U.S. Department of Health & Human Services | National Institutes of Health (R01AI148491, R01AI119015, R01AI132850)
Article History
Received: 30 January 2023
Accepted: 26 September 2023
First Online: 16 November 2023
Competing interests
: Y.Z.’s company FormuMax is interested in the sales of exosome-mimicking liposomes. The other authors declare no competing interests.